Primo Nery Lara
Hematology & Oncology · Regents of the Univ of Ca
Credentials: · ·
History
- 1996–1999
- 1991–1992
University of the Philippines
Research
New England Journal of Medicine · 2004 · 3,019 citations
Journal of Clinical Oncology · 2018 · 673 citations
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 571 citations
136 papers · 18 as a fellow
- DL
38 papers
37 papers
36 papers
- AD
32 papers
26 papers
- CP
24 papers · 1 as a fellow
- IT
24 papers · 4 as a resident
Grants
- 2014–2032
SWOG Network Group Operations Center of the NCTN
National Cancer Institute · U10
Contact PI · $32.2M · University of California at Davis
- 2002–2031
Cancer Center Support Grant P30
National Cancer Institute · P30
Contact PI · $39.1M · University of California at Davis
- 2009–2027
UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development Program
National Cancer Institute · K12
Contact PI · $10.6M · University of California at Davis
- 2014–2027
Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTN
National Cancer Institute · UM1
PI · $11.5M · Beckman Research Institute/City of Hope
Clinical trials
- 2016–2021
Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer
Principal investigator · Completed · Phase 1, Phase 2
University of California, Davis
- 2015–2020
Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer
Principal investigator · Completed · Phase 1
University of California, Davis
- 2011–2015
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2010–2012
Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors
Principal investigator · Completed · Phase 1
University of California, Davis